ArticleFrontiers in oncology2022

HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review.

Min-Long Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.